A hydroxy steroid carrying a hydroxy group at position 17.
ChEBI ID: 36838
| Member | Definition | Role |
|---|---|---|
| 17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol | 19-Nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17beta-diol | |
| algestone | A C21-steroid that is pregn-4-ene substituted by oxo groups at position 3 and 20 and hydroxy groups at positions 16 and 17. | algestone |
| androstane-3,17-diol | androstane-3,17-diol | |
| dexamethasone 21-phosphate | A steroid phosphate that is the 21-O-phospho derivative of dexamethasone. | dexamethasone phosphate |
| ethinyl estradiol | A 3-hydroxy steroid that is estradiol substituted by a ethynyl group at position 17. It is a xenoestrogen synthesized from estradiol and has been shown to exhibit high estrogenic potency on oral administration. | 17alpha-ethynylestradiol |
| quinestrol | quinestrol |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4,754 (46.07) | 18.7374 |
| 1990's | 1,477 (14.31) | 18.2507 |
| 2000's | 1,835 (17.78) | 29.6817 |
| 2010's | 1,858 (18.01) | 24.3611 |
| 2020's | 394 (3.82) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 1,752 (15.95%) | 5.53% |
| Reviews | 481 (4.38%) | 6.00% |
| Case Studies | 523 (4.76%) | 4.05% |
| Observational | 22 (0.20%) | 0.25% |
| Other | 8,206 (74.71%) | 84.16% |